资讯
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work ...
Major Obamacare insurer Oscar Health is warning Congress and the Trump administration of the political ramifications of ...
In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果